[The Role of C-CAT, the Repository Database of Cancer Genomic Medicine in Japan].
Cancer somatic clinical sequencing has been emerging as a norm in the advanced countries. The Expert Meeting for Cancer Genomic Medicine Promotion Consortium publicized its report on June 27, 2017 in The Ministry of Health, Labour website. The report depicts the grand design for the implementation of the genomic medicine in Japan. The Expert Meeting recommends a step-wise approach; such a novel medical practice should be first conducted only in designated hospitals, and the number of these hospitals shall be increased gradually. Another important proposal from the Expert Meeting is to install a central data repository to aggregate genomic and clinical information of the cancer genomic medicine. In response, the Ministry launched The Center for Cancer Genomics and Advanced Therapeutics(C-CAT)in June 2018. While several countries and industries have been intensively promoting acquisition and enclosure of genomic medicine real world data, it is our urgent agenda in Japan to establish the next-generation infrastructure for medical care and innovation based on the collaboration and understanding by the stakeholders, including the patients, families, citizens and medical staff.